377.00
+4.00
+(1.07%)
At close: April 11 at 4:59:54 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | 29.3 | 2.6 |
| Low Estimate | 0 | 0 | 29.3 | 2.6 |
| High Estimate | 0 | 0 | 29.3 | 2.6 |
| Year Ago EPS | -- | -- | -- | 29.3 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | -- | -- | 2.92B | 634.98M |
| Low Estimate | -- | -- | 2.92B | 634.98M |
| High Estimate | -- | -- | 2.92B | 634.98M |
| Year Ago Sales | -- | -- | -- | 2.92B |
| Sales Growth (year/est) | -- | -- | -- | -78.26% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 29.3 | 2.6 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GUBRA.CO | -- | -- | -- | -91.13% |
| S&P 500 | 6.40% | 6.07% | 9.36% | 14.28% |
Related Tickers
ZEAL.CO Zealand Pharma A/S
427.70
-0.28%
GMAB.CO Genmab A/S
1,225.00
+0.66%
BAVA.CO Bavarian Nordic A/S
145.85
+0.24%
ALK-B.CO ALK-Abelló A/S
140.60
+2.33%
PILA.ST Pila Pharma AB (publ)
3.0550
-4.53%
GMAB Genmab A/S
18.81
+4.44%
SANION.ST Saniona AB (publ)
6.72
-0.59%
EVAX Evaxion Biotech A/S
1.3500
+0.75%
ASND Ascendis Pharma A/S
150.99
+5.34%
FLUO.ST FluoGuide A/S
40.90
+11.44%